FMC Corporation (FRA:FMQ)
Germany · Delayed Price · Currency is EUR | Market Cap | 701.46M -78.0% |
| Revenue (ttm) | 2.85B -21.3% |
| Net Income | -2.42B |
| EPS | -19.64 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 4.69 |
| Dividend | 0.28 (6.15%) |
| Ex-Dividend Date | Sep 30, 2026 |
| Volume | 938 |
| Open | 4.465 |
| Previous Close | 4.461 |
| Day's Range | 4.360 - 4.549 |
| 52-Week Range | 3.942 - 26.330 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 29, 2026 |
About FMC Corporation
FMC Corporation, an agricultural sciences company, develops, markets, and sells crop protection chemicals in Latin America, North America, Europe, the Middle East, Africa, and Asia. The company offers crop protection chemicals, including insecticides, herbicides, and fungicides. It also provides biologicals, crop nutrition, and seed treatment products. It markets its products through its sales organization and alliance partners, independent distributors, and sales representatives. The company was founded in 1883 and is headquartered in Philadel... [Read more]
News
Lost Money on FMC Corporation Shares? The Law Offices of Frank R.
LOS ANGELES--(BUSINESS WIRE)--FMC Corporation ("FMC" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investig...
Did You Lose Money on FMC Corporation Stock? The Law Offices of Howard G.
BENSALEM, Pa.--(BUSINESS WIRE)--Investors who suffered losses on FMC Corporation ("FMC" or the "Company") stock may have claims to recover those losses. The Law Offices of Howard G. Smith today report...
FMC Investors with $100,000 in Losses Have Opportunity to Join FMC Corporation Fraud Investigation with SBS Law
LOS ANGELES--(BUSINESS WIRE)---- $FMC--FMC Investors with $100,000 in Losses Have Opportunity to Join FMC Corporation Fraud Investigation with SBS Law.
FMC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving FMC Corporation
FMC guided for as much as $140 million in third-quarter adjusted EBITDA, then reset the outlook to a loss of as much as $565 million. The investigation is on behalf of shareholders who lost money in t...
FMC price target lowered to $6 from $12 at Citi
Citi analyst Patrick Cunningham lowered the firm’s price target on FMC (FMC) to $6 from $12 and keeps a Neutral rating on the shares.
FMC Stock Dropped 31%—Why It May Still Be No Bargain
FMC's steep selloff hasn't erased concerns about its debt and inventory problems, while rival Corteva looks more attractive.
FMC price target lowered to $7.50 from $11 at BMO Capital
BMO Capital lowered the firm’s price target on FMC (FMC) to $7.50 from $11 and keeps a Market Perform rating on the shares after the company’s negative Q3 pre-announcement. Years…
FMC downgraded to Hold from Buy at Jefferies
Jefferies downgraded FMC (FMC) to Hold from Buy with a price target of $5, down from $14. To reduce customer inventory and stimulate sales to growers, FMC lowered the price…
FMC downgraded to Neutral from Buy at Seaport Research
Seaport Research analyst Michael Harrison downgraded FMC (FMC) to Neutral from Buy.
FMC price target lowered to $10 from $12 at Mizuho
Mizuho analyst Edlain Rodriguez lowered the firm’s price target on FMC (FMC) to $10 from $12 and keeps an Outperform rating on the shares. FMC is taking a $625M-$650M charge…
Corteva exposure to generic pressure ‘more modest’ than FMC, says Citi
After FMC (FMC) cut revenue and adjusted EBITDA forecasts and noted weaker than expected demand and elevated high-priced channel inventory limiting replenishment demand, Citi notes that the company’s ...
RBC Capital sees negative reaction to FMC’s Q3 preannouncement
RBC Capital tells investors in a research note that FMC (FMC) slashed Q3 EBITDA guidance to $538M from the previous midpoint of $130M, largely due to $650M in commercial actions,…
FMC price target lowered to $4 from $9 at Barclays
Barclays analyst Benjamin Theurer lowered the firm’s price target on FMC (FMC) to $4 from $9 and keeps an Underweight rating on the shares. The company cut its fiscal Q3…
FMC price target lowered to $9 from $11 at RBC Capital
RBC Capital lowered the firm’s price target on FMC (FMC) to $9 from $11 and keeps a Sector Perform rating on the shares as part of a broader research note…
FMC Stock Plummets 38% on Horrendous Guidance
Shares of crop chemical maker FMC plunged Thursday after the company provided deeply disappointing guidance.
FMC provides overview of commercial actions
The critical commercial issue facing FMC (FMC) is slower-than-expected demand from channel customers in key markets. Under current market conditions, distributors are seeking to operate with the lowes...
FMC down 28% to $5.85 after cutting Q3 guidance
07:37 EDT FMC (FMC) down 28% to $5.85 after cutting Q3 guidance
FMC Corporation Provides Update to Third-Quarter Expectations and Announces Comprehensive Commercial Actions to Expedite Return to Growth
Third-quarter revenue 1 is now expected to be $65 million to $125 million, with Adjusted EBITDA 2 expected to be negative $565 million to negative $510 million Revised expectations now include commerc...
FMC price target lowered to $12 from $15 at Mizuho
Mizuho analyst Edlain Rodriguez lowered the firm’s price target on FMC (FMC) to $12 from $15 and keeps an Outperform rating on the shares. The firm adjusted targets in the…
FMC price target lowered to $11 from $14 at BMO Capital
BMO Capital lowered the firm’s price target on FMC (FMC) to $11 from $14 and keeps a Market Perform rating on the shares as part of a broader research note…
FMC price target lowered to $10 from $12 at UBS
UBS lowered the firm’s price target on FMC (FMC) to $10 from $12 and keeps a Neutral rating on the shares.
FMC submits regulatory dossier for rimisoxafen to Brazilian authorities
FMC (FMC) announced the submission of the regulatory dossier for rimisoxafen to Brazilian regulatory authorities. The filing marks the second global regulatory submission for rimisoxafen, the first an...
FMC Corporation Submits Regulatory Dossier for Rimisoxafen, the Industry's First Dual Mode of Action Herbicide, in Brazil
Second global filing advances rimisoxafen as a novel weed control solution for Brazil's more than 70 million hectares of corn and soybeans PHILADELPHIA, Sept. 28, 2026 /PRNewswire/ -- FMC Corporation ...
FMC Corporation and Tessenderlo Group Complete Minority Equity Investment
PHILADELPHIA, Sept. 23, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, and Tessenderlo Group (XBRU: TESB), a Belgian-based industrial group, today an...
FMC Corporation announces date for third quarter 2026 earnings release and webcast conference call
PHILADELPHIA, Sept. 21, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) announced today it will release its third quarter 2026 earnings on Thursday, October 29, 2026, after the stock market close via...